These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32803868)

  • 1. Combating Antibiotic-Resistant Gram-Negative Bacteria Strains with Tetracycline-Conjugated Carbon Nanoparticles.
    Kim TH; Raiz A; Unni AD; Murhekar S; Donose BC; Floetenmeyer M; Cock IE; Brown CL
    Adv Biosyst; 2020 Sep; 4(9):e2000074. PubMed ID: 32803868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidrug efflux pumps in Gram-negative bacteria and their role in antibiotic resistance.
    Blair JM; Richmond GE; Piddock LJ
    Future Microbiol; 2014; 9(10):1165-77. PubMed ID: 25405886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broad-specificity efflux pumps and their role in multidrug resistance of Gram-negative bacteria.
    Nikaido H; Pagès JM
    FEMS Microbiol Rev; 2012 Mar; 36(2):340-63. PubMed ID: 21707670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tannic acid affects the phenotype of Staphylococcus aureus resistant to tetracycline and erythromycin by inhibition of efflux pumps.
    Tintino SR; Morais-Tintino CD; Campina FF; Costa MDS; Menezes IRA; de Matos YMLS; Calixto-Júnior JT; Pereira PS; Siqueira-Junior JP; Leal-Balbino TC; Coutinho HDM; Balbino VQ
    Bioorg Chem; 2017 Oct; 74():197-200. PubMed ID: 28841421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergy between Active Efflux and Outer Membrane Diffusion Defines Rules of Antibiotic Permeation into Gram-Negative Bacteria.
    Krishnamoorthy G; Leus IV; Weeks JW; Wolloscheck D; Rybenkov VV; Zgurskaya HI
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089426
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reviving Antibiotics: Efflux Pump Inhibitors That Interact with AcrA, a Membrane Fusion Protein of the AcrAB-TolC Multidrug Efflux Pump.
    Abdali N; Parks JM; Haynes KM; Chaney JL; Green AT; Wolloscheck D; Walker JK; Rybenkov VV; Baudry J; Smith JC; Zgurskaya HI
    ACS Infect Dis; 2017 Jan; 3(1):89-98. PubMed ID: 27768847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring the activity of active efflux in gram-negative bacteria.
    Webber MA; Coldham NG
    Methods Mol Biol; 2010; 642():173-80. PubMed ID: 20401594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Tobramycin Vector Enhances Synergy and Efficacy of Efflux Pump Inhibitors against Multidrug-Resistant Gram-Negative Bacteria.
    Yang X; Goswami S; Gorityala BK; Domalaon R; Lyu Y; Kumar A; Zhanel GG; Schweizer F
    J Med Chem; 2017 May; 60(9):3913-3932. PubMed ID: 28399372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.
    Li XZ; Plésiat P; Nikaido H
    Clin Microbiol Rev; 2015 Apr; 28(2):337-418. PubMed ID: 25788514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An original deal for new molecule: reversal of efflux pump activity, a rational strategy to combat gram-negative resistant bacteria.
    Pagès JM; Amaral L; Fanning S
    Curr Med Chem; 2011; 18(19):2969-80. PubMed ID: 21651484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-envelope multidrug efflux pumps of Gram-negative bacteria and their synergism with the outer membrane barrier.
    Zgurskaya HI; Rybenkov VV; Krishnamoorthy G; Leus IV
    Res Microbiol; 2018; 169(7-8):351-356. PubMed ID: 29454787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of efflux pump inhibitors to treat Gram-negative infections.
    Blanco P; Sanz-García F; Hernando-Amado S; Martínez JL; Alcalde-Rico M
    Expert Opin Drug Discov; 2018 Oct; 13(10):919-931. PubMed ID: 30198793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multidrug efflux pumps and their role in antibiotic and antiseptic resistance: a pharmacodynamic perspective.
    Alibert S; N'gompaza Diarra J; Hernandez J; Stutzmann A; Fouad M; Boyer G; Pagès JM
    Expert Opin Drug Metab Toxicol; 2017 Mar; 13(3):301-309. PubMed ID: 27764576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An alkylaminoquinazoline restores antibiotic activity in Gram-negative resistant isolates.
    Mahamoud A; Chevalier J; Baitiche M; Adam E; Pagès JM
    Microbiology (Reading); 2011 Feb; 157(Pt 2):566-571. PubMed ID: 21071494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Essential oils from Moroccan plants as potential chemosensitisers restoring antibiotic activity in resistant Gram-negative bacteria.
    Fadli M; Chevalier J; Saad A; Mezrioui NE; Hassani L; Pages JM
    Int J Antimicrob Agents; 2011 Oct; 38(4):325-30. PubMed ID: 21752605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibacterial and antibiotic-resistance modifying activity of the extracts and compounds from Nauclea pobeguinii against Gram-negative multi-drug resistant phenotypes.
    Seukep JA; Sandjo LP; Ngadjui BT; Kuete V
    BMC Complement Altern Med; 2016 Jul; 16():193. PubMed ID: 27386848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efflux pumps of gram-negative bacteria, a new target for new molecules.
    Pagès JM; Sandrine AF; Mahamoud A; Bolla JM; Davin-Regli A; Chevalier J; Garnotel E
    Curr Top Med Chem; 2010; 10(18):1848-57. PubMed ID: 20615189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efflux Pump Inhibitors: A Novel Approach to Combat Efflux-Mediated Drug Resistance in Bacteria.
    Wang Y; Venter H; Ma S
    Curr Drug Targets; 2016; 17(6):702-19. PubMed ID: 26424403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of efflux pumps in Gram-negative bacteria.
    Pagès JM; Masi M; Barbe J
    Trends Mol Med; 2005 Aug; 11(8):382-9. PubMed ID: 15996519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-antibiotics, Efflux Pumps and Drug Resistance of Gram-negative Rods.
    Laudy AE
    Pol J Microbiol; 2018 Jun; 67(2):129-135. PubMed ID: 30015451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.